Trump’s Order: AI Laws Blockade May Hinder Health AI Growth
“`html
Trump Management blocks state AI Regulations, Raising Concerns for Healthcare
Executive Order and It’s Implications
On December 11, 2025, President Trump signed an executive order
aimed at preempting state laws regulating artificial intelligence (AI). The order intends too foster U.S.leadership in AI growth but has sparked debate regarding patient safety and the role of health systems in adopting AI technologies. The administration argues that a patchwork of state regulations hinders innovation and competitiveness.
The order’s primary effect is to streamline compliance for AI companies operating across state lines. However, critics contend this federal intervention could undermine efforts to establish safeguards against potential harms caused by AI in healthcare. This is particularly concerning given the increasing deployment of AI in critical areas like diagnosis, treatment planning, and insurance claims processing.
Rising Concerns About AI in Healthcare: A timeline of Legal Challenges
The executive order arrives amidst a growing number of legal challenges and scrutiny surrounding the use of AI in healthcare. several lawsuits allege that AI-driven systems are causing demonstrable harm to patients.
-
December 2023: lawsuits were filed against Humana
alleging that its AI algorithms improperly denied necessary medical care to Medicare Advantage patients. -
February 2025: A lawsuit against UnitedHealth Group
advanced, claiming the company used AI to systematically deny coverage for patient care. The case highlights concerns about algorithmic bias and lack of openness in AI-driven decision-making.
-
November 2025: Lawsuits emerged alleging wrongful deaths and mental breakdowns
linked to the use of AI chatbots, specifically OpenAI‘s ChatGPT.These cases raise questions about the duty of AI developers for the psychological impact of their products. -
October 2025: Senator Richard Blumenthal sent a letter to major health insurers - UnitedHealth, Humana, CVS Health, and Aetna – demanding data about their use of AI
>
in Medicare Advantage plans.
Federal Legislation and the Regulatory Void
The executive order’s timing is meaningful, as Congress has yet to enact comprehensive federal legislation addressing AI privacy or regulation. This legislative gap leaves a void that the Trump administration is now attempting to fill through executive action. the absence of federal standards creates uncertainty for both AI developers and healthcare providers.
The lack of clear federal guidelines also complicates efforts to establish accountability when AI systems cause harm. Without defined standards for transparency, fairness, and safety, it is difficult to determine who is responsible for algorithmic errors or biased outcomes.
Impact on Stakeholders
The executive order is expected to have different impacts on various stakeholders:
| Stakeholder | Expected Impact |
|---|
